At a glance
- Originator Sanofi Winthrop
- Class Cardiotonics; Vasodilators
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 25 Aug 1997 No-Development-Reported for Hypertension in USA (Unknown route)
- 07 Aug 1995 New profile
- 07 Aug 1995 Preclinical development for Hypertension in USA (Unknown route)